No article content yet.
Timeline
No Timeline data yet.
Invested in
Patents
Further Resources
No Further Resources data yet.
Mr. Goeltz has an extensive track record and breadth of experience in finance and accounting, most recently serving as Chief Financial Officer and Senior Vice President of UNITY Biotechnology and immediately before that as Chief Financial Officer of CytomX Therapeutics, leading both of the companies’ IPOs and finance organizations.